Tamtam Try Tamtam free
Acadia Healthcare logo

Acadia Healthcare account plan

Comprehensive behavioral health treatment

At a glance

Acadia Healthcare is a US behavioral healthcare provider with 280 facilities, about 12,800 beds, $3,312.8 million FY2025 revenue and about 25,000 employees.

Acadia Healthcare Company (NASDAQ: ACHC), headquartered in Franklin, Tennessee, runs acute psychiatric hospitals, addiction treatment facilities, outpatient opioid treatment centers and residential treatment centers across 40 states and Puerto Rico. Its stated strategy is to become the indispensable behavioral healthcare provider for high-acuity and complex-needs patients. FY2025 revenue was $3,312.8 million, up 5.0%, but a $996.2 million goodwill impairment led to a net loss attributable to Acadia of $1,102.8 million. Revenue is government-heavy: 57.7% Medicaid, 24.6% commercial and 14.3% Medicare in FY2025. At September 30, 2026 it operated 280 facilities with approximately 12,800 beds, and it has about 25,000 employees.

Business units

Strategic priorities

Ramp new facilities to $200 million of EBITDA
Management targets $200 million of incremental adjusted EBITDA relative to 2025 from facilities opened since 2023, with about $60 million expected in 2027 as startup losses fall from about $45 million to around $10 million.
Operational execution under the returning CEO
Debra Osteen restructured acute operations into smaller divisions, created a new operating group for JV hospitals and recently opened facilities, removed a middle management layer and reduced corporate headcount.
Organic growth of existing facilities
Acadia aims to broaden services, add beds and improve underperforming facilities; management sees patient day growth in a 3%-4% range going forward.
Revenue cycle and payer work
With bad debts and denials worse than expected in early 2026, Acadia is improving documentation of patient acuity, appealing denials and rolling out technology and analytic tools, including early AI in revenue cycle management.
Capital discipline
2026 capex was cut to $210-230 million from $571.8 million in 2025, and the 2027 plan focuses on existing facilities and maintenance with no new facilities for now.

Latest results

In Q3 2026 (quarter ended September 30, 2026) revenue was $895.3 million, up 5.1%, and same facility revenue grew 5.2%, with admissions up 6.6% and revenue per patient day up 4.0%. Net income attributable to Acadia was $34.5 million against $36.2 million a year earlier, and adjusted EBITDA was $176.4 million. Nine-month revenue was $2,590.0 million (+4.0%), and operating cash flow rose to $321.5 million while capex fell to $165.9 million. Guidance was raised for the third consecutive quarter: 2026 revenue of $3.44-3.46 billion, adjusted EBITDA of $615-625 million and adjusted EPS of $1.70-1.80.

Investments and deals

New beds and joint ventures
Acadia added 1,089 beds in 2025, including five JV facilities with Henry Ford Health, Geisinger Health, Ascension Seton, Fairview Health Services and ECU Health, and 542 beds in the first nine months of 2026, including JVs with Tufts Medicine, Orlando Health and Methodist Jennie Edmundson.
Coastal Pines de novo
The 144-bed Coastal Pines Behavioral Health near Jacksonville is the fourth new acute facility opened in 2026 and the 16th since the beginning of 2023.
Capex reduction
Capex was $571.8 million in 2025 ($467.4 million expansion, $104.4 million maintenance) and $165.9 million in the first nine months of 2026, against $478.6 million a year earlier.
Refinancing and buyback
In 2025 Acadia signed a $1.0 billion revolving facility and a $650.0 million term loan maturing in 2030, issued $550.0 million of 7.375% Senior Notes due 2033 and authorised a $300.0 million share buyback, of which $250.0 million remains.

Challenges and risks

Government investigations and litigation
DOJ Criminal Division and SEC investigations into acute care admissions, length of stay and billing remain open; the 2019 Securities Litigation settled for $179.0 million and a 2025 securities class action survived a motion to dismiss.
Medicaid policy changes
The One Big Beautiful Bill Act adds Medicaid work requirements in expansion states by December 31, 2026 and caps state directed payments, while enhanced ACA premium tax credits expired on December 31, 2025.
New York referrals to Pennsylvania
New York's Medicaid change cut same facility revenue growth by about 1 point and volume growth by about 2.6 points; replacing those patients is still a work in progress, according to management.
Denials and bad debts
Bad debts and payer denials worsened in Q1 2026 in a way management called more broad-based, and days sales outstanding rose to 52 from 49 at year-end 2025.
Liability and labor costs
A $28.6 million unfavourable adjustment to professional and general liability reserves was booked in the first nine months of 2026, and management describes the labor market as very tight.

What leadership says

“our primary focus is operational execution and deriving more value from our facilities and recent bed additions.”

Debra K. Osteen, Chief Executive Officer · Acadia Healthcare Q1 2026 Earnings Call, 2026-04-30

“We remain confident in this group delivering on $200 million of adjusted EBITDA growth relative to 2025.”

Debra K. Osteen, Chief Executive Officer · Acadia Healthcare Q1 2026 Earnings Call, 2026-04-30

“documentation is the key to what we do”

Debra K. Osteen, Chief Executive Officer · Acadia Healthcare Q1 2026 Earnings Call, on revenue cycle, 2026-04-30

“my goal when I returned as CEO was to position Acadia for long-term success.”

Debra K. Osteen, Chief Executive Officer · Acadia Healthcare Q3 2026 Earnings Call, 2026-11-05

Where a supplier can help

Revenue cycle and denial management
Tied to the denials and bad debts challenge and the revenue cycle priority: clinical documentation, denial appeal and revenue cycle AI vendors fit a company already piloting AI there.
Ramping new facilities
Tied to the $200 million EBITDA ramp priority: referral marketing, patient-intake and staffing partners can help new facilities fill beds and cut startup losses.
Compliance and investigation readiness
Tied to the government investigations challenge: compliance, clinical audit and legal technology providers can support documentation of admissions, length of stay and billing.
Workforce recruiting and retention
Tied to the liability and labor costs challenge: recruiting and workforce tools can support centralised hiring of facility CEOs and RNs in a very tight labor market.
Maintenance of an existing footprint
Tied to the capital discipline priority: facility maintenance and building services suppliers fit a 2027 plan focused on existing facilities rather than new builds.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Acadia Healthcare?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Acadia Healthcare

What does Acadia Healthcare do?

Acadia provides behavioral healthcare services in the US through acute psychiatric hospitals, addiction treatment facilities, outpatient opioid treatment centers and residential treatment centers.

What is Acadia Healthcare's revenue?

FY2025 revenue was $3,312.8 million, up 5.0%. The company guides to 2026 revenue of $3.44-3.46 billion.

How many employees does Acadia Healthcare have?

Acadia has approximately 25,000 employees, about 19,000 of them full-time.

What is Acadia Healthcare's strategy?

Acadia is focused on operational execution: ramping the 16 facilities opened since 2023 toward $200 million of incremental adjusted EBITDA, growing existing facilities and cutting capex.

Who leads Acadia Healthcare?

Debra K. Osteen returned as Chief Executive Officer in 2026, and David Duckworth is Interim CFO.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)